top of page
Post: Blog2_Post

"We Removed Nitro From Our STEMI Guideline" w/ Matt Schneider


In this episode, we talk with Matt Schneider, a Battalion Chief and Paramedic for the Mequon fire department in Ozaukee County. Sam and I had the privilege of sitting in on a guideline update presented by Matt a few weeks ago. One of the guidelines that caught our attention was the decision to remove nitroglycerin from the STEMI guideline.


We have discussed nitro in ACS several times on FOAMfrat. The benefit versus risk has been an interesting topic amongst clinicians.




Here are the guidelines we refer to in this episode:

STEMI
.pdf
Download PDF • 180KB

ChestPain
.pdf
Download PDF • 330KB

"Matt's views, comments, and opinions expressed in this segment do not represent the position of his employer(s), or associated agencies/institutions".


Matt said feel free to email him with any questions you have!

mschneider@ci.mequon.wi.us


The audio-only podcast can be found on your favorite podcast platform




References:

Bangalore S.,(2010). What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?


Kobayashi, A., Misumida, N., Fox, J. T., & Kanei, Y. (2015). Prognostic Value of Left Ventricular end-diastolic Pressure in Patients With Non-ST-Segment Elevation Myocardial Infarction. Cardiology Research, 6(4-5), 301–305. doi:10.14740/cr406w


Park, H., Hong, Y. J., Cho, J. Y., Sim, D. S., Yoon, H. J., Kim, K. H., … Korean Acute Myocardial Infarction Registry Investigators (2017). Blood Pressure Targets and Clinical Outcomes in Patients with Acute Myocardial Infarction. Korean circulation journal, 47(4), 446–454. doi:10.4070/kcj.2017.0008


Relationship of Blood Pressure and Cardiovascular Events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 Trial Originally published23 Nov 2010https://doi.org/10.1161/CIRCULATIONAHA.109.905687Circulation. 2010;122:2142–2151

bottom of page